25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients

被引:12
|
作者
Nguyen, Nguyen N. [1 ]
Raju, Muppala N. P. [1 ]
da Graca, Briget [2 ]
Wang, Dapeng [1 ]
Mohamed, Nada A. [1 ]
Mutnal, Manohar B. [1 ]
Rao, Arundhati [1 ]
Bennett, Monica [2 ]
Gokingco, Matthew [1 ]
Huy Pham [1 ]
Mohammad, Amin A. [1 ]
机构
[1] Baylor Scott & White Cent Texas, Dept Pathol, Temple, TX 76508 USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
来源
PLOS ONE | 2022年 / 17卷 / 05期
关键词
VITAMIN-D; HEALTH;
D O I
10.1371/journal.pone.0268038
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes. Methods We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher's exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used. Results COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29 [1.53-18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10-6.90]). Conclusions There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are useful for assessing the odds of mortality and the need for ventilation during hospitalization.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D
    Hutchings, Nicholas
    Babalyan, Varta
    Baghdasaryan, Sisak
    Qefoyan, Mushegh
    Sargsyants, Narina
    Aghajanova, Elena
    Martirosyan, Anna
    Harutyunyan, Ruzanna
    Lesnyak, Olga
    Formenti, Anna Maria
    Giustina, Andrea
    Bilezikian, John P.
    ENDOCRINE, 2021, 71 (02) : 267 - 269
  • [2] Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D
    Nicholas Hutchings
    Varta Babalyan
    Sisak Baghdasaryan
    Mushegh Qefoyan
    Narina Sargsyants
    Elena Aghajanova
    Anna Martirosyan
    Ruzanna Harutyunyan
    Olga Lesnyak
    Anna Maria Formenti
    Andrea Giustina
    John P. Bilezikian
    Endocrine, 2021, 71 : 267 - 269
  • [3] Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity
    Panagiotou, Grigorios
    Tee, Su Ann
    Ihsan, Yasir
    Athar, Waseem
    Marchitelli, Gabriella
    Kelly, Donna
    Boot, Christopher S.
    Stock, Nadia
    Macfarlane, James
    Martineau, Adrian R.
    Burns, Graham
    Quinton, Richard
    CLINICAL ENDOCRINOLOGY, 2020, 93 (04) : 508 - 511
  • [4] Association between 25-hydroxyvitamin D levels and COVID-19 severity
    Takase, Tomoki
    Tsugawa, Naoko
    Sugiyama, Takayuki
    Ikesue, Hiroaki
    Eto, Masaaki
    Hashida, Tohru
    Tomii, Keisuke
    Muroi, Nobuyuki
    CLINICAL NUTRITION ESPEN, 2022, 49 : 256 - 263
  • [5] Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19
    Jevalikar, Ganesh
    Mithal, Ambrish
    Singh, Anshu
    Sharma, Rutuja
    Farooqui, Khalid J.
    Mahendru, Shama
    Dewan, Arun
    Budhiraja, Sandeep
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19
    Ganesh Jevalikar
    Ambrish Mithal
    Anshu Singh
    Rutuja Sharma
    Khalid J. Farooqui
    Shama Mahendru
    Arun Dewan
    Sandeep Budhiraja
    Scientific Reports, 11
  • [7] In response to: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity
    Brown, Miles
    CLINICAL ENDOCRINOLOGY, 2020, 93 (05) : 630 - 631
  • [8] A notable key for estimating the severity of COVID-19: 25-hydroxyvitamin D status
    Tuncay, Merve Ergin
    Gemcioglu, Emin
    Kayaaslan, Bircan
    Ates, Ihsan
    Guner, Rahmet
    Eser, Fatma
    Hasanoglu, Imran
    Kalem, Ayse Kaya
    Aypak, Adalet
    Agac, Zubeyr Said
    Bektas, Serife Gokbulut
    Mungan, Ibrahim
    Akdag, Ahmet Gokhan
    Izdes, Seval
    Neselioglu, Salim
    Erel, Ozcan
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2021, 46 (02): : 167 - 172
  • [9] Original publication: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity
    Panagiotou, Grigorios
    Tee, Su Ann
    Ihsan, Yasir
    Athar, Waseem
    Marchitelli, Gabriella
    Kelly, Donna
    Boot, Christopher S.
    Stock, Nadia
    Macfarlane, James
    Martineau, Adrian R.
    Burns, Graham P.
    Quinton, Richard
    CLINICAL ENDOCRINOLOGY, 2020, 93 (05) : 629 - 630
  • [10] Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study
    Mbata, Munachimso Kizito
    Hunziker, Mireille
    Makhdoomi, Anja
    Luethi-Corridori, Giorgia
    Boesing, Maria
    Giezendanner, Stephanie
    Muser, Juergen
    Leuppi-Taegtmeyer, Anne B.
    Leuppi, Joerg D.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)